Sareum (LON:SAR) Share Price Crosses Below 50-Day Moving Average – Here’s Why

Sareum Holdings plc (LON:SAR) shares passed below its 50 day moving average during trading on Tuesday . The stock has a 50 day moving average of GBX 16.79 and traded as low as GBX 16. Sareum shares last traded at GBX 16.50, with a volume of 61,602 shares.

Sareum Stock Performance

The company has a fifty day simple moving average of GBX 16.79 and a two-hundred day simple moving average of GBX 18.09. The firm has a market capitalization of £22.37 million, a PE ratio of -4.50 and a beta of -1.08.

About Sareum

Sareum is a specialist drug development company delivering targeted small molecule therapeutics to improve the treatment of cancer and autoimmune diseases. The Company aims to generate value through licensing its candidates to international pharmaceutical and biotechnology companies at the preclinical or early clinical trials stage.
Sareum is advancing internal programmes focused on distinct dual tyrosine kinase 2 (TYK2) / Janus kinase 1 (JAK1) inhibitors through preclinical development as therapies for autoimmune diseases, including the ‘cytokine storm’ immune system overreaction to Covid-19 and other viral infections, (SDC-1801) and cancer immunotherapy (SDC-1802).
Sareum also has an economic interest in SRA737, a clinical-stage oral, selective Checkpoint kinase 1 (Chk1) inhibitor that targets cancer cell replication and DNA damage repair mechanisms.